Comparison of efficacy and complications of Nasal intermittent positive pressure ventilation (NIPPV) and nasal continuous positive airway pressure (NCPAP) in preterm infants
- Conditions
- respiratory distress in neonates.Respiratory distress syndrome of newbornsp22,p22.0,
- Registration Number
- IRCT201202273250N6
- Lead Sponsor
- Kerman university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
All consecutively born preterm infants with gestational age 28 to 36 weeks, admitted to Afzalipour neonatal intensive care unit with respiratory distress and silverman- Anderson retraction score of 6 and 7. Exclusion criteria: Babies were excluded if there was signiicant morbidity apart from RDS including cardiac disease, congenital malformation including congenital diapheragmatic hernia, tracheoeso phageal fistula and cleft lip/palate, babies with respiratory distress secondary to severe asphyxia (Apgar score <3 at 1 and 5 minute or PH<7/12 or if they had cardiovascular or respiratory instability because of sepsis, anemia or severe intraventriculare hemorrhage (IVH) on admission.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to treatment. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: comparing survival rates.
- Secondary Outcome Measures
Name Time Method Incidence of pneumothorax. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Taking chest x rays on admission and deterioration of clinical status.;Incidence of PDA. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Echo cardiography on admission and deterioration of clinical status.;Incidence of IVH. Timepoint: During hospitalization and using NCPAPand NIPPV. Method of measurement: Cranial ultra sonography on admission and deterioration of clinical status.